Skip to content

Comment on What's going on with gene therapies?parent

Comments

It's also just hard. Biology is hard. Being a startup in a heavily regulated field, rather than the "What if $Industry but with no regulations?" of the Uber/AirBnB model, and where iteration doesn't necessarily show returns makes life for biotech startups difficult.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.